Melatonin Teva

Melatonin, the active ingredient in Melatonin Teva, is a melatonin receptor agonist presented as an oral dosage form for oral use. It helps regulate the sleep‑wake cycle and is used to manage insomnia, other sleep disorders and jet lag in adults.

GNH USA supplies Melatonin Teva as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Melatonin Teva acts on melatonin receptors to support normal circadian rhythm and facilitate sleep onset.

- Insomnia: improves sleep initiation and duration in individuals with difficulty falling asleep. - Sleep disorders: assists in the management of broader sleep‑related conditions such as delayed sleep phase syndrome. - Jet lag: helps synchronize the internal clock after rapid time‑zone travel, reducing fatigue and daytime sleepiness.

Melatonin Teva is generally well tolerated, but adverse reactions can occur.

Common Side Effects: - Drowsiness or daytime sleepiness - Headache - Dizziness - Nausea or mild stomach upset - Vivid dreams or nightmares - Mild fatigue

Serious or Rare Side Effects: - Allergic reactions such as rash, itching or swelling - Severe skin reactions (e.g., Stevens‑Johnson syndrome) - Mood changes including depression or anxiety - Seizures (rare) - Hallucinations or psychotic symptoms - Abnormal heart rhythm or palpitations

When using Melatonin Teva, consider the following safety measures.

- Assess sleep hygiene: evaluate and improve bedtime routines before initiating therapy. - Use lowest effective dose: start with the smallest dose that provides benefit. - Avoid operating machinery: refrain from driving or using heavy equipment if residual drowsiness occurs. - Hypersensitivity: discontinue if signs of allergic reaction appear. - Hepatic impairment: use with caution in patients with liver disease, as metabolism may be altered. - Store at ambient temperature: keep in the original container, protect from moisture and direct sunlight.

Melatonin may interact with other medicines; monitoring is advised.

Major Interactions (Avoid): - Anticoagulants (e.g., warfarin): increased risk of bleeding. - Immunosuppressants (e.g., cyclosporine): possible reduction in immunosuppressive effect. - Hormonal contraceptives: may diminish contraceptive efficacy.

Moderate Interactions (Monitor Closely): - Central nervous system depressants (e.g., benzodiazepines): additive sedative effect. - Antidiabetic agents (e.g., insulin): potential alteration of glucose control. - Antiepileptic drugs (e.g., carbamazepine): may affect melatonin metabolism. - CYP enzyme inhibitors (e.g., fluvoxamine): can raise melatonin plasma levels.